How Quickly We Need To Ramp Up Vaccinations To Get To Herd Immunity
Debate about how many vaccinations are needed by when has been in the news. Drew Altman lays it out in his latest column.
View the Latest: Vaccines
Filter
-
-
Vaccine Monitor: Nearly Half of the Public Wants to Get a COVID-19 Vaccine as Soon as They Can or Has Already Been Vaccinated, Up across Racial and Ethnic Groups Since December
News ReleaseMost Convincing Messages to Promote Vaccination Highlight Effectiveness at Preventing Illness and a Return to Normal Life; Hearing about Rare Allergic Reactions and Side Effects May Discourage Some New KFF Dashboard Features Key Data and Insights from the Vaccine Monitor With millions of Americans getting their first COVID-19 vaccinations, the public’s eagerness to get a vaccine is rising across racial and ethnic groups, though Republicans and rural residents remain the most reluctant groups, the latest…
-
Data as of February 1 on State Vaccinations by Race/Ethnicity
News ReleaseUpdated analysis of state-reported data as of February 1, 2021 on COVID-19 vaccinations, cases, and deaths by race/ethnicity is now available. Based on nearly half of states reporting vaccination data by race/ethnicity, Black and Hispanic people continue to receive smaller shares of vaccinations compared to their shares of cases and deaths and compared to their proportions of the total population. In all 23 states reporting data, Black people account for a smaller share of vaccinations compared…
-
KFF COVID-19 Vaccine Monitor: December 2020
ReportThis initial survey for the KFF COVID-19 Vaccine Monitor tracks the public’s attitudes and experiences with COVID-19 vaccinations, with a focus on sub-groups of Americans. It explores confidence in vaccines, assesses trust in messengers, and highlights key challenges for vaccination efforts.
-
KFF Launches New COVID-19 Vaccine Monitor to Track the Public’s Confidence in the Vaccine and Experiences for the Duration of the Pandemic
News ReleaseRepublicans and Black Americans are More Likely to Be Hesitant but Even Among These Groups Reasons Vary KFF has launched a new COVID-19 Vaccine Monitor to dive deeply into the public’s views about the vaccine and experiences getting it for as long as the pandemic lasts. First results released today show that Americans’ enthusiasm for getting a COVID-19 vaccination varies substantially across groups, with Republicans and Black Americans among those most hesitant. Overall, 71% of…
-
Gaps in Cost Sharing Protections for COVID-19 Testing and Treatment Could Spark Public Concerns About COVID-19 Vaccine Costs
Issue BriefIn the issue brief, KFF experts highlight the laws and regulations that are in place to ensure access to free COVID-19 vaccines for individuals regardless of their insurance status and explain how vaccine administration costs will be covered in private insurance, Medicare and Medicaid, and for the uninsured.
-
KFF Health Tracking Poll – May 2021: Prescription Drug Prices Top Public’s Health Care Priorities
FeatureThe latest KFF Health Tracking Poll explores the public's views on the U.S. role in distributing COVID vaccines to other countries, health care priorities for Congress, prescription drug regulations and price negotiations, and affordability changes in the COVID-19 relief bill.
-
Vaccine Hesitancy in Rural America
Poll FindingBased on data from the KFF COVID-19 Vaccine Monitor, this poll finding explores attitudes among rural Americans toward the coronavirus and willingness to get a potential vaccine.
-
Analysis: Rural Residents Stand Out as One of the Most Hesitant Groups to Get a COVID-19 Vaccine and Pose Special Challenges for the Mass Vaccination Efforts
News ReleaseA new analysis of KFF COVID-19 Vaccine Monitor survey data finds that residents of rural America stand out as one of the groups most hesitant to get a COVID-19 vaccine and that their views about the pandemic could pose significant challenges for the nation’s mass vaccination effort. About a third (35%) of people living in rural areas say they probably or definitely would not get a COVID-19 vaccine that had been deemed safe and effective…
-
COVID-19 Vaccination Rates Among Children Under 5 Have Peaked and Are Decreasing Just Weeks Into Their Eligibility
Issue BriefChildren between the ages of 6 months and 5 years of age finally became eligible for COVID-19 vaccination in the U.S. on June 18, after the Director of the Centers for Disease Control and Prevention (CDC) recommended their use for this population, following emergency use authorization granted by the Food and Drug Administration. Here, we examine the status of vaccine uptake in this group, one month into their eligibility.